LSBC, ApoImmune protein production deal

Large Scale Biology (LSBC) will produce two of ApoImmune's polypeptides for use as cancer vaccine adjuvants. The deal combines LSBC's GeneWare manufacturing technology with ProtEx cancer cell targetin...